Home › Funds › AMI ASSET MANAGEMENT CORP › WST

AMI ASSET MANAGEMENT CORP position in WST

WEST PHARMACEUTICAL SVSC INC · Health Care

AMI ASSET MANAGEMENT CORP reported holding 141,556 shares of WST (WEST PHARMACEUTICAL SVSC INC) in its Q3 2026 13F filing — a position valued at US$52.5M, representing 3.33% of its reported portfolio and ranking #10 among its reported holdings. AMI ASSET MANAGEMENT CORP has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)141.56K sh
Reported value held$52.48M
Portfolio Weight3.33%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How AMI ASSET MANAGEMENT CORP's WST position evolved

AMI ASSET MANAGEMENT CORP first disclosed a stake in WST in Q3 2023 at 160,560 shares (US$60.2M). The position peaked in Q1 2024 at 164,738 shares, worth US$65.2M. Across 13 filings, AMI ASSET MANAGEMENT CORP increased the stake 2 time(s), trimmed it 10 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 141,556 shares valued at US$52.5M — a reduction of -5,208 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 160.56K $60.24M New
Q4 2023 159.52K $56.17M Reduce
Q1 2024 164.74K $65.19M Add
Q2 2024 159.93K $52.68M Reduce
Q3 2024 184.15K $55.27M Add
Q4 2024 182.66K $59.83M Reduce
Q1 2025 173.80K $38.91M Reduce
Q2 2025 165.31K $36.17M Reduce
Q3 2025 163.00K $42.76M Reduce
Q4 2025 159.04K $43.76M Reduce
Q1 2026 154.40K $38.70M Reduce
Q2 2026 146.76K $52.69M Reduce
Q3 2026 141.56K $52.48M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About WST and 13F data

WST (WEST PHARMACEUTICAL SVSC INC) is a Health Care company. 28 other funds we track also report a position in WST — the largest reported positions include Artisan Partners Limited Partnership (US$744.4M), GENERATION INVESTMENT MANAGEMENT LLP (US$728.2M), BROWN ADVISORY INC (US$386.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding WST

All WST fund holders →

FAQ

How long has AMI ASSET MANAGEMENT CORP held WST?

AMI ASSET MANAGEMENT CORP has disclosed WST holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is AMI ASSET MANAGEMENT CORP's current position in WST?

As of Q3 2026, AMI ASSET MANAGEMENT CORP holds 141.56K shares of WST (WEST PHARMACEUTICAL SVSC INC), valued at $52.48M, representing 3.33% of its reported portfolio and ranking #10.

Has AMI ASSET MANAGEMENT CORP been buying or selling WST?

In the latest 13F filing (Q3 2026), AMI ASSET MANAGEMENT CORP reduced its position in WST. The position peaked in Q1 2024 at 164.74K shares.

Which other funds hold WST?

Other major institutional holders of WST include Artisan Partners Limited Partnership, GENERATION INVESTMENT MANAGEMENT LLP, BROWN ADVISORY INC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.